Miracle Mile Advisors, LLC Eli Lilly & CO Transaction History

Miracle Mile Advisors, LLC

$4.15 Billion
Q3 2024

A detailed history of Miracle Mile Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Miracle Mile Advisors, LLC holds 7,019 shares of LLY stock, worth $5.52 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

7,019

Previous 6,410 9.5%

Holding current value

$5.52 Million

Previous $5.8 Million 7.15%

% of portfolio

0.15%

Previous 0.14%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 07, 2024	BUY	$772.14 - $960.02 $470,233 - $584,652	609 Added 9.5%	7,019 $6.22 Million
Q2 2024 Jul 18, 2024	BUY	$724.87 - $909.04 $483,488 - $606,329	667 Added 11.61%	6,410 $5.8 Million
Q1 2024 Apr 18, 2024	BUY	$592.2 - $792.28 $355,320 - $475,368	600 Added 11.67%	5,743 $4.47 Million
Q4 2023 Jan 22, 2024	BUY	$525.19 - $619.13 $256,817 - $302,754	489 Added 10.51%	5,143 $3 Million
Q3 2023 Oct 25, 2023	BUY	$434.7 - $599.3 $11,736 - $16,181	27 Added 0.58%	4,654 $2.5 Million
Q2 2023 Jul 13, 2023	SELL	$350.74 - $468.98 $140,296 - $187,592	-400 Reduced 7.96%	4,627 $2.17 Million
Q1 2023 Apr 20, 2023	BUY	$310.63 - $364.82 $29,199 - $34,293	94 Added 1.91%	5,027 $1.73 Million
Q4 2022 Jan 20, 2023	BUY	$321.55 - $374.67 $222,834 - $259,646	693 Added 16.34%	4,933 $0
Q3 2022 Oct 24, 2022	BUY	$296.48 - $337.87 $665,004 - $757,842	2,243 Added 112.32%	4,240 $1.37 Million
Q2 2022 Jul 15, 2022	BUY	$278.73 - $327.27 $131,839 - $154,798	473 Added 31.04%	1,997 $647,000
Q1 2022 Apr 25, 2022	SELL	$234.69 - $291.66 $3.45 Million - $4.29 Million	-14,704 Reduced 90.61%	1,524 $437,000
Q4 2021 Jan 18, 2022	BUY	$224.85 - $279.04 $22,709 - $28,183	101 Added 0.63%	16,228 $4.48 Million
Q3 2021 Nov 01, 2021	SELL	$221.6 - $272.71 $18,614 - $22,907	-84 Reduced 0.52%	16,127 $3.73 Million
Q2 2021 Jul 28, 2021	SELL	$180.55 - $233.54 $295,740 - $382,538	-1,638 Reduced 9.18%	16,211 $3.72 Million
Q1 2021 Apr 29, 2021	SELL	$164.32 - $212.72 $114,038 - $147,627	-694 Reduced 3.74%	17,849 $3.33 Million
Q4 2020 Jan 19, 2021	BUY	$130.46 - $172.63 $58,315 - $77,165	447 Added 2.47%	18,543 $3.13 Million
Q3 2020 Nov 12, 2020	BUY	$146.22 - $169.13 $471,705 - $545,613	3,226 Added 21.69%	18,096 $2.68 Million
Q2 2020 Aug 06, 2020	BUY	$136.42 - $164.18 $2.03 Million - $2.44 Million	14,870 New	14,870 $2.44 Million

Others Institutions Holding LLY

# of Institutions

3,994

Shares Held

752M

Call Options Held

7.31M

Put Options Held

9.23M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $747B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Miracle Mile Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Miracle Mile Advisors, LLC with notifications on news.

Account

Miracle Mile Advisors, LLC Eli Lilly & CO Transaction History